| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |